COVID-19 and stroke: pathophysiological mechanisms
PDF (Portuguese (Brazil))

Keywords

COVID-19
Stroke
Pathophysiology

How to Cite

COVID-19 and stroke: pathophysiological mechanisms. (2026). Electronic Journal Collection Health, 26(11), e25247. https://doi.org/10.25248/reas.e25247.2026

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To analyze the scientific evidence available on the pathophysiological mechanisms involved in the association between SARS-CoV-2 infection and stroke, integrating the main biological processes described in the literature. Methods: This is an integrative literature review, conducted according to the method proposed by Whittemore and Knafl, with searches performed in the PubMed/MEDLINE, BVS, and CAPES Periodicals Portal databases, using the descriptors COVID-19, Stroke, and Pathophysiology, combined with the AND operator, covering publications from January 2021 to June 2026. Results: Of the 711 studies identified, 14 composed the final sample, revealing seven recurring pathophysiological axes: renin-angiotensin-aldosterone system dysregulation, cerebral endotheliopathy, immunothrombosis, blood-brain barrier degradation, neuroinvasion and mitochondrial dysfunction, systemic hypoxia with cardioembolism, and persistent endothelial dysfunction in long COVID, revealing COVID-19 as a multisystemic vascular disease associated with increased cerebrovascular risk. Final considerations: This study reinforces the central role of thromboinflammation and endothelial injury in the pathophysiology of COVID-19-associated stroke, although gaps remain regarding the contribution of direct viral neuroinvasion and the duration of post-infection vascular alterations.

PDF (Portuguese (Brazil))

References

AGHAYARI SNS, et al. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Frontiers in Cardiovascular Medicine, 2021; 8: 649922.

BOTELHO LLR, et al. O método da revisão integrativa nos estudos organizacionais. Gestão e Sociedade, 2011; 5(11): 121.

CABRAL MPG, et al. Acorda morte na pandemia de Covid-19: epidemiologia social crítica, interseccionalidade e necropolítica. Physis: Revista de Saúde Coletiva, 2024; 34: e34053.

CAO W, et al. Ischemic Stroke: An Underestimated Complication of COVID-19. Aging and Disease, 2021; 12(3): 692-704.

CHAVDA V, et al. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurological International, 2022; 14(2): 391-405.

ELROBAAI H, NEW KJ. COVID-19: Pulmonary and Extra Pulmonary Manifestations. Frontiers in Public Health, 2021; 9: 711616.

GHASEMI M, et al. SARS-CoV-2 and Acute Cerebrovascular Events: An Overview. Journal of Clinical Medicine, 2021; 10(15): 3349.

KAKARLA V, et al. Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2. Journal of Cerebral Blood Flow & Metabolism, 2021; 41(6): 1179-1192.

KING A, DOYLE KM. Implications of COVID-19 to Stroke Medicine: An Epidemiological and Pathophysiological Perspective. Current Vascular Pharmacology, 2022; 20(4): 333-340.

MENDES KDS, et al. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto Enfermagem, 2008; 17(4): 758-764.

MBONDE AA, et al. Stroke Features, Risk Factors, and Pathophysiology in SARS-CoV-2–Infected Patients. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2022; 6(2): 156-165.

REHMAN SU, et al. COVID-19 challenges and its therapeutics. Biomedicine & Pharmacotherapy, 2021; 142: 112015.

SADEGHMOUSAVI S, REZAEI N. COVID-19 infection and stroke risk. Reviews in the Neurosciences, 2020; 32(4): 453-465.

SAGRIS D, et al. COVID-19 and ischemic stroke. European Journal of Neurology, 2021; 28(11): 3826-3836.

SASHINDRANATH M, NANDURKAR HH. Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19. Stroke, 2021; 52(5): 1895-1904.

SMALL C, et al. Coronavirus Disease-2019 and Stroke: Pathophysiology and Management. Canadian Journal of Neurological Sciences, 2023; 50(4): 495-502.

STAMM B, et al. Pathomechanisms and Treatment Implications for Stroke in COVID-19: A Review of the Literature. Life, 2022; 12(2): 207.

STEFANOU E, et al. Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review. Current Treatment Options in Neurology, 2023; 25: 71–92.

STOJANOVIC M, et al. Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review. International Journal of Molecular Sciences, 2025; 27(1): 433.

VASHISHT A, et al. Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications. Viruses, 2024; 16(8): 1183.

WIJERATNE T, et al. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review. Frontiers in Neurology, 2021; 11: 607221.

WHITTEMORE R, KNAFL K. A revisão integrativa: metodologia atualizada. Revista de Enfermagem Avançada, 2005; 52(5): 546-553.

ZHANG S, et al. COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review). International Journal of Molecular Medicine, 2021; 47(3): 4854.